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Abstract
Biomaterials utilized in biomedical applications are of various characteristics and 
cements are unique in their in situ, biomimetic formation ability. They present the most 
topographically complex surfaces that usually elicit a favorable cellular response for tis-
sue regeneration. In addition their composition may provide an effective chemical gradi-
ent around the resorbing implant to induce desired cellular activity that leads to rapid 
wound healing and regeneration. These are the main reasons for many cement systems 
to function well in the body, especially as hard tissue replacements. The properties and 
the setting mechanisms of the clinically most relevant cement system, calcium phosphate 
cements have been elucidated in this chapter.
Keywords: calcium phosphate cement, calcium orthophosphates, inorganic bone 
cement, cement injectability, cement setting kinetics, cement biocompatibility, 
orthopaedic cements
1. Introduction
In the simplest sense cement is a binder of functional solid materials. Biomedical materials 
that necessitate combination with a binder are usually strong, inert metals and ceramics that 
are implanted in order to augment defects in hard tissues such as bone and dentin. For a long 
time since the Second World War, this binding function had been fulfilled by organic cements 
that gain elasticity by crosslinking in situ. Polymethylmethacrylate and various other resins 
that display a rapid rise in viscosity and elasticity upon addition of chemicals or exposure to 
light have been widely accepted as effective cements despite their commonly encountered 
biocompatibility issues due to the release of irritating monomers and inflammatory heat of 
setting. Inorganic cements emerged later thanks to the advances in materials characterization 
techniques and understanding of the molecular mechanisms of bioactivity. Calcium sulfate, 
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zinc phosphate, zinc polycarboxylate, magnesium phosphate, calcium phosphate, calcium 
silicate and glass polyalkenoate cements all proved to be biocompatible and to some degree 
osteoconductive. Particularly the effectiveness of calcium phosphate cements (CPC) as bio-
materials has been attributed largely to their similar composition to hard tissues, aqueous 
setting solutions and tailorable viscosity. In addition constant improvements in cement prop-
erties have been realized due to their biomimetic setting reactions at ambient conditions that 
enabled experimenting with a wide variety of chemical and biological additives. As a result, 
inorganic cements led in quantity by calcium phosphate cements have been applied as bulk 
materials to fill defects in bone and teeth, support, induce and conduct bone regeneration 
rather than just bind more effective biomaterials in isolation. As highlighted in the subsequent 
parts of this chapter, biological interaction of calcium phosphate cements with human cells 
have been tested extensively and provides the basis for various modification approaches to 
extend their applications and facilitate their evolution toward the ideal biomaterial.
Inherent solubility of most calcium compounds in water has been a major motivation for material 
scientists to research and discover novel cementitious systems of these materials. So was the dis-
covery of the major class of inorganic biomedical cements, calcium phosphate cements, realized. 
CPCs were discovered by LeGeros, Brown and Chow in early 1980s as an alternative to bulky 
bone graft bioceramics to set in situ and fill bone or dental defects [1, 2]. According to Chow, the 
discovery of the first CPC was in fact a result of basic studies on calcium phosphate solubility 
behaviors for the purpose of development of a tooth remineralizing suspension similar to con-
temporary toothpaste formulations. Based on solubility phase diagrams, material scientists were 
aware of the fact that both tetracalcium phosphate (TTCP) and dicalcium phosphate anhydrate 
(DCP) are much more soluble than hydroxyapatite (HA) under neutral pH conditions. Further, 
a slurry containing appropriate amounts of these compounds can produce continuous HA pre-
cipitation while maintaining the solution composition relatively constant. Brown and Chow 
observed that some of the TTCP + DCP aqueous pastes became a hardened mass when left in test 
tubes for a few hours. Thus unaware of the beneficial biomedical consequences, they discovered 
a new type of bioactive, self-hardening cement that consisted of only calcium phosphates and 
formed HA as the product. Rigorous subsequent in vivo research on the same cement system led 
to the conclusion that implanted CPC was gradually replaced by new bone. This CPC composi-
tion received approval by the US Food and Drug Administration in 1996, thus becoming the first 
commercially available CPC for use in humans [3]. Since then, many compositions have been 
proposed, most of which are given in the following sections.
2. Applications
Compared to sintered calcium phosphate ceramics which are the most commonly applied mate-
rials in orthopedic surgery, calcium phosphate cements have three major advantages. Firstly, 
CPCs are nanocrystalline and hence have a very high specific surface area. Values as high as 
100 m2/g can be reached. In comparison, sintered ceramics have surface areas close to or below 
1 m2/g. Secondly, CPCs enable the synthesis of granules and blocks of low-temperature calcium 
phosphates such as dicalcium phosphate dihydrate (DCPD), dicalcium phosphate anhydrate, 
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octacalcium phosphate (OCP), or precipitated apatite (PHA) [4]. In addition, initial flowability 
of CPCs enable their convenient conveying to the surgical site by means of a pressurization 
equipment and easy shaping by hand to conform to the defect perfectly. Injectability and suf-
ficient compressive strength of CPCs has expanded their use to minimally invasive surgeries like 
percutaneous vertebroplasty and balloon kyphoplasty where organic polymethylmethacrylate 
(PMMA) cements had previously been the only choice for the surgeon to fill bone defects or fix 
bulk implants to the defect site [5, 6]. Due to the superiority of CPCs to PMMA in many aspects 
including bioactivity [7–9], dimensional stability [10], and biomimetic hardening, these materials 
are gradually replacing the organic bone cements especially in minimally invasive operations.
Calcium phosphate bone cement pastes typically exhibit relatively low shear viscosity and 
elastic modulus, then gain elasticity and shear viscosity with time. The rates of growths of the 
elasticity and viscosity of calcium phosphate based cements are generally higher than those 
of conventional cements as a result of the rapid dissolution and crystallization of calcium 
phosphate particles in water. Their initial flowability and workability are exploited most com-
monly in biomedical applications for bone repair and regeneration due to their exceptional 
osteoconductivity especially following cancerous bone removal and for minimally invasive 
surgeries. The minimally invasive clinical applications of bone cement pastes include spinal 
fusion, vertebroplasty, khyphoplasty, cranioplasty and periodontal surgery. During surgical 
applications the precise placement of the bone cement paste by the surgeon is very impor-
tant. Various means are available for the placement of the cement paste into the repair site. 
Generally a syringe with a needle can be used. Calcium phosphate cements must react slowly 
enough to provide enough time for the surgeon to inject and work the paste into the implan-
tation site, and fast enough to prevent washing-out or delaying the wound closure. Also its 
setting time and extent of reaction should be balanced to impart strength to the final product. 
The initial setting time is critical as it should allow sufficient time for shaping and filling. 
After the filling, it is not advisable to disturb the set cement until its hardening because any 
mechanical strain during this period will produce cracks and adversely affect the strength. 
Therefore it requires the shortest possible final setting time so that the wound closure is not 
delayed. The initial setting time denotes the end of workability of the paste after wetting, and 
the final setting time indicates the hardening of the set mass [11]. An initial setting time of 
about 8 minutes and a final setting time of less than 15 minutes are recommended for ortho-
pedic applications.
Typically after setting of calcium phosphate cements, aqueous setting liquid is trapped in 
micro-reservoirs. The release of incorporated ions enable continuous hardening for days after 
setting. This reservoir effect is beneficial for many aqueous inorganic cements but especially 
for biomedical applications because of the contribution of the material to the dynamic tissue 
remodeling processes. Inorganic bone cements are required to provide a temporary support for 
the activity of the bone microenvironment consisting of cells, proteins, growth factors and ions 
while simultaneously facilitating the natural remodeling process by providing a preferentially 
alkaline environment and an abundance of relevant ions of calcium, phosphate, carbonate, etc. 
An excellent explanation of the bone remodeling process from a materials scientist’s perspec-
tive by Driessens et al. is recommended for more information [12]. Exceptional bioactivity of 
apatite forming CPCs is due to the alkaline microenvironment rich in calcium and phosphate 
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ions in ratio similar to those in the bone extracellular matrix. In addition, the inherent micropo-
rosity of these materials is beneficial for the release of drugs, and biomolecules that are proven 
to direct cellular activity so as to facilitate a wound healing and remodeling process close to 
natural as possible [13]. However macroporosity is also needed to be able to make use of these 
macromolecule osteoinductive factors like bone morphogenetic protein, transforming growth 
factor, platelet-derived growth factor, basic fibroblast growth factor and enable invasion of the 
material by osteoblasts [14]. Generally interconnected pores of sizes in excess of 300 μm are rec-
ommended to enhance new bone formation and the formation of capillaries [15]. Various mac-
ropore induction techniques have been applied to these biomimetically setting pastes with ease 
but those that work in situ are the most suitable for orthopedic applications [16–19]. Precise 
control on the porous architecture of calcium phosphate cement based scaffolds have been real-
ized in a number of recent studies by indirect 3D printing techniques [20, 21]. The dimensional 
accuracy and bioactivity of such custom-fit forms of the material were found outstanding.
3. Properties
3.1. Bioactivity
As the chemical composition of the mammalian bone mineral is similar to ion-substituted, cal-
cium-deficient hydroxyapatite (CDHA), apatite forming calcium phosphate cements have been 
more extensively investigated as bioactive implant materials than brushite forming CPCs. All 
apatite CPC formulations have precipitated hydroxyapatite (PHA) as the end-product of the reac-
tion which has a much finer crystal structure than its sintered counterparts or other CPC setting 
products including brushite and monetite. High surface area and roughness are the physical req-
uisites for osteoconduction as bone bonding is achieved by micro-mechanical interdigitation of 
the cement line (a thick apatite layer secreted by osteoblasts) with the material surface [22]. Also 
micro-topographically complex surfaces promote osteoconduction by both increasing the avail-
able surface area for fibrin attachment and providing surface features with which fibrin becomes 
entangled; and potentiating the activation of platelets, which produce density gradients of cyto-
kines and growth factors that guide leukocytes and osteogenic cells during the healing process 
[23]. Furthermore Davies demonstrated that platelet activation on calcium phosphate surfaces 
is a function of the surface topography of the calcium phosphate, rather than the composition.
According to Davies, the formation of bone requires not only the recruitment and migra-
tion of a potentially osteogenic cell population but also the differentiation of this population 
into mature secretory cells [24]. The potentially osteogenic population migrates through the 
wound site and reaches the surface of bone fragments, or the implant within the wound site. 
This stage termed osteoconduction is the most important aspect of peri-implant healing. The 
implant surface design can have a profound influence on osteoconduction not only by modu-
lating the levels of platelet activation, but also by maintaining the anchorage of the temporary 
scaffold of fibrin and proteins through which these cells reach the implant surface. Cells that 
reach the solid surface will initiate matrix synthesis by secreting the first collagenous matrix 
of the cement line directly on the implant surface. This new bone formation stage is gener-
ally considered as a separate and distinct phenomenon and is followed by remodeling of the 
bone. The bone bonding theory of Davies helps one understand how calcium phosphate and 
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most other inorganic cements provide the advantages of accelerating early healing and bone 
bonding over most other biomaterials. Calcium phosphates are known to readily adsorb pro-
teins to their surfaces. Potentiating protein adsorption on calcium phosphate surfaces can be 
expected to increase the binding of fibrinogen that may lead to increased platelet adhesion 
and, possibly result in increased platelet activation that may accelerate healing. Increasing 
protein adsorption can also include an improvement in fibrin binding to the implant surface 
resulting in an earlier establishment of the three-dimensional matrix through which osteo-
genic cells have to migrate to reach the implant surface. Therefore surface micro-topography 
and chemistry of calcium phosphates are critical for both the osteoconduction, and also the 
bonding of the elaborated bone matrix to that surface.
Aside from osteoconductivity, the most important requirement for a bone substitute implant 
material is biocompatibility. It is defined by Williams as [25]: “The ability of a biomaterial to 
perform its desired function with respect to a medical therapy, without eliciting any undesir-
able local or systemic effects in the recipient or beneficiary of that therapy, but generating the 
most appropriate beneficial cellular or tissue response in that specific situation, and optimiz-
ing the clinically relevant performance of that therapy.” Orthopedic and maxillofacial implants 
are designed for non-sustained, short-term contact meaning that the implant should degrade 
in time. Therefore the implant material is required to have a level of degradability in the body 
in addition to the appropriate beneficial cellular response to be biocompatible. The physical 
presence of particulate or ionic degradation products are able to stimulate inflammatory cells, 
especially macrophages and giant cells that may elicit a systematic response and lead to a 
foreign body reaction to the biomaterial. Therefore biomaterial and its degradation products 
have to be devoid of any potential for mutagenicity, genotoxicity, carcinogenicity, reproduc-
tive toxicity and other adverse systematic effects in order to be considered biocompatible.
In this context apatite and brushite CPCs are biocompatible and osteoconductive. Calcium 
phosphate cements form an apatite layer on the surface shortly after implantation in bone. 
However, a unique feature of cements is that the particles are mixed with each other and the 
force linking them is weak; therefore, these particles can easily detach from the cement body, 
especially after some dissolution has occurred. When this happens, the particles are easily 
ingested by osteoclast-like cells or by giant cells [26]. However, inflammatory reactions and 
cytotoxicity have been reported when large brushite CPC volumes were used, primarily due 
to the transformation to precipitated HA and the resultant release of phosphoric acid [27, 28]. 
The transformation of DCPD into PHA can be prevented by adding magnesium ions to the 
cement paste [29] and converting brushite to the more stable anhydrous form, monetite [30]. 
The latter has been achieved by various techniques including heating [31], water deficient 
setting [32], acidic setting [33] and high ionic strength [34]. Some inflammatory reactions due 
to the initial acidity of brushite cement precursors may also apparently occur when the CPC 
does not set since the pH gradually increases close to the physiological level upon setting. The 
addition of collagen to brushite cement at different powder-to-liquid ratios resulted in an up 
to ninefold reduction in the amount of particles released from the cement when compared 
to the control cement without collagen. Collagen effectively prevented particle loss from the 
submerged cement paste during setting. In addition brushite-collagen cement composites 
had a three-fold increased cell adhesion capacity [35]. Numerous other in vivo and in vitro 
assessments have reported that calcium phosphates always support the attachment, differen-
tiation, and proliferation of osteoblasts and mesenchymal cells, with hydroxyapatites being 
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the most efficient among them [36, 37]. CPCs are not generally considered to be osteoinduc-
tive. However their drug delivery capability has been effectively exploited to impart osteoin-
ductivity to various CPC formulations [16, 38].
3.2. Mechanical properties
The mechanical properties of calcium phosphate cements depend on two conditions: (a) the 
precipitate should grow in the form of clusters of crystals which have a high degree of rigidity, 
(b) the morphology of the crystals should enable entanglement of the clusters. In Driessen’s 
study of 450 different CPC formulations, about 40% set in a time shorter than 60 minutes [39]. 
However, only part of these formulations led to cement bodies having a considerable strength. 
It was found that both compressive and diametral tensile strength were maximum for stoi-
chiometric compositions with respect to the reaction products. Strength is also related to pore 
structure due to the size distribution of all the particles and the pressure applied to compact the 
particle network. Thus, the early compressive strength of the cement is mainly dependent on 
the quantity of the hydration products, the amount of contact points among hydrated grains, 
and the volume proportion of hydration product crystals [40]. In addition to the above-men-
tioned factors, the final compressive strength is obviously dependent on the degree of dissolu-
tion, recrystallization, growth and intergrowth of cement precursor and product crystals [41].
Both the extent of CPC conversion and the compressive strength of the cement increase drasti-
cally with time in the form of a sigmoidal function [42, 43]. In common practice, the observation 
of the initial plateau strength values is prevented by the requirement of sample rigidity and the 
finite time period of strength measurements, so that an exponential rise with time and an end 
plateau is reported in mechanical characterization results. The complete variation of cement 
strength and modulus as a function setting time can be conveniently observed using a mechan-
ical spectrometer that is able to probe the viscoelastic character of the cement suspension [44, 
45]. The compressive strength is highly correlated with the extent of conversion of the reactants 
to the products. After setting, CPCs can reach mechanical properties comparable to those of 
calcium phosphate blocks with the same porosity. Having the ceramic origin, the set products 
of all calcium orthophosphate cements are brittle, have both a low impact resistance and a low 
tensile strength within 1–10 MPa, whereas the compressive strength varies within 10–100 MPa. 
Brushite cements are slightly weaker than apatite cements. However their innovative modifi-
cation methods result in exceptional strength because of the water consuming setting reaction 
of brushite cements [46]. Unlike apatite cements, which consume little (1 mole per 3 moles of 
powder reactant in β-tricalcium phosphate (β-TCP) systems) or no water (TTCP/DCP systems) 
during setting, the brushite cement system consumes a lot of water during setting reaction (up 
to 6 moles per 1 mole of powder reactant), theoretically allowing for the formation of cements 
with low or almost zero porosities. Some excellent reviews on the mechanical properties of 
both apatite and brushite cements are recommended for additional information [26, 47, 48]. In 
macroporous form apatite cement has adequate strength to replace trabecular bone. In vivo, 
the mechanical properties of apatite cements were found to increase, whereas those of brushite 
cements decreased [49, 50]. This is generally attributed to a higher bioresorbability of DCPD 
when compared with that of CDHA which not only depends on the inherent solubility but also 
on various physiological processes occurring around the implant site [51].
Cement Based Materials196
One of the main reasons for the weakness of CPCs is their inherent microporosity, which 
makes it easier for micro- and macro-cracks to run throughout the mass [14]. The pores that 
typically account for about 40% of hardened cement volume, originate from water reser-
voirs that form due to packing imperfections, shrinkage, drying and water consuming set-
ting reaction. Porosity may be controlled to a certain extent by precompaction [52], adjusting 
the particle size [53, 54] and the powder/liquid (P/L) ratio [46], addition of porogens [55] 
and rheology enhancing chemical [56]. Combination of precompaction with citric acid due 
to its liquefying effect results in outstanding strength values. Unusually high strengths can 
also be obtained when cement P/L ratio is maximized to the limiting level of insufficient 
wetting. This is possible by either efficient dispersion of particle agglomerates through a 
liquefying effect due to electrostatic repulsion of particles or by using bimodal particle size 
distribution in the setting cement. Various organic and inorganic chemicals including alpha-
hydroxylic acids (a.k.a. carboxylic acids), and vinylic superplasticizers have been utilized for 
increasing the surface charge by binding to the active surface sites [56, 57]. Bimodal particle 
size distributions have been shown to decrease the water demand in an α-tricalcium phos-
phate (α-TCP) single-component, HA-forming system where the addition of an CaCO
3
 filler 
of much smaller particle size enabled higher workable P/L [58]. In the case of macropore 
introduction to the cement matrix by incorporation of porogens, the microporosity is simply 
decreased because the sample contains less CPC per unit volume due to more macroporos-
ity. Although this is beneficial for the resorbability of the cement, mechanical properties of 
macroporous cement are greatly reduced compared to macropore free cements. According 
to Rice, strength of ceramics vary as an exponential function of porosity as given below and 
so does the strength of CPCs [59]:
  σ =  σ 
0
 exp  (− KP) (1)
where σ
0
 is the strength of the material with zero porosity and K is a constant. This equation 
is modified by Le Huec to take pore size into account accordingly [60]:
  σ =  ( E 0 R /  (𝜋c) ) 0.5 exp (− KP) (2)
where E
0
 is the modulus of zero porosity, c is the average pore size and R is fracture surface 
energy.
Fiber reinforcement is one of the most convenient methods to compensate for the induced 
macroporosity in CPCs [61, 62]. Certain fibers like aramid have the property of bonding 
with hydroxyapatite and providing nucleation sites for set crystals. This property of aramid 
was made use of in the study by Xu et al. where fiber reinforcement imparted a substantial 
improvement of mechanical properties over those of fiber free porous cement, with strength 
increasing 3–7 times and toughness by 2 orders of magnitude [55]. The porosity values of the 
fiber composites were slightly less than those without fibers because the 6% mass imparted by 
the reinforcing fibers was fully dense.
Other factors affecting strength are the materials used in the solid phase, incorporation and 
particle size/shape of filler materials in the solid phase. Several researchers attempted to add 
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filler materials to increase the mechanical properties as in a composite matrix [63, 64]. The 
idea behind the use of filler particles is that if a tough filler is present in the matrix, it may 
stop crack Propagation. However by adding fillers porosity decreases, as does the ability of 
the material to allow bone ingrowth into the pores. Using bioresorbable polymers as fillers 
provides an effective solution to this problem [65, 66].
3.3. Injectability
Injectability of CPCs is of crucial importance for surgical procedures utilizing minimally inva-
sive procedures such as in vertebraplasty and kyphoplasty or for delivery of the cement into 
a very narrow space as in root canal obturation. During the injection of the cement paste a 
pressure drop of the ceramic paste is developed as the paste flows out of the syringe and the 
needle and as it is forced into the treatment site. This pressure drop represents the bottle neck 
to injection and is overcome by the surgeon applying a higher pressure on the ram of the 
syringe that holds the cement. The applicability and the injectability of the cement suspen-
sion are governed by the time-dependent shear viscosity and elasticity of the ceramic paste 
(functions of all parameters affecting the setting kinetics). Once the ceramic suspension attains 
certain upper thresholds of viscosity and elasticity the injection of the cement paste to the 
treatment site is no longer possible. A rapid increase in the shear viscosity of the cement paste 
(transition from flowable suspension to a gel and then to a rigid solid) that is associated with 
the cement reaching its setting time, restricts the duration of time that the cement remains 
viable for injection during surgery. Usual practice for the orthopedic surgeon is to change 
cement formulations that include various setting retarder or promoter chemicals in addition 
to the setting precursors, according to the time limitations of the task. Alternatively, the set-
ting time and flowability of calcium phosphate cements are adjustable in situ by the novel 
preshearing technology through application of oscillatory and torsional shear strains prior to 
pressurization and delivery to the surgical site which gives the surgeon freedom to use a wide 
range of cement formulations that set at various times [44].
At the initial period after mixing with the setting liquid, cements consist of dissolving particles in 
an aqueous solution that is gradually enriching in precursor ions. This dynamic microstructure 
with constantly changing maximum packing ratio and solid content typically exhibits concomi-
tant slow alterations in the cement flow behavior according to the Krieger-Dougherty model:
  η r  =  (1 −    φ ____  φ  max   ) −n (3)
where  η r is the relative viscosity (the ratio between the cement and the setting liquid viscosi-
ties),  φ​ and  φ 
max
 are the volume fraction of particles in suspension and the volume fraction at 
which viscosity approaches infinity, respectively, and n is the intrinsic viscosity, an experi-
mentally determinable constant (2.5 for spherical particles). Calcium phosphate cements show 
a shear-thinning behavior by a significant yield stress that increases with time. They are visco-
plastic and can be described as Herschel-Bulkley fluids at any instant but lose their plasticity 
with time [67]. Furthermore, these materials are thixotropic [68]. The rheological behavior of 
the cement pastes are strongly influenced by the change of the surface charge during setting. 
The formation of agglomerates upon mixing the cement powder with the setting liquid can be 
minimized by taking advantage of the electrostatic repulsion between highly charged surfaces. 
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The Zeta potential is an important property of cement particles influencing not just particle 
coagulation but also ion exchange between the hydrate layer around the ceramic particle and 
the particle surface itself as well as the net precipitation of new material [69].
CPC injectability depends on many factors and may be quite poor in certain cases which 
results in liquid-solid phase separation called filter-pressing. Their capillary flow has been 
analyzed extensively in order to understand their injectability behavior [70, 71]. The com-
mon observation has been the overshot pressure that is needed to extrude the whole cement 
sample out, in other words clogging. Highly filled suspensions stably flowing inside a barrel 
exhibit a constant pressure vs. time curve as seen in Figure 1a. Binder phase migrates toward 
the direction of applied pressure starting at time t
0
 and leaves a percolated particle network 
termed mat behind as shown in Figure 1b. Filtration of the low viscosity binder is caused 
by weak adhesion between the particles and the binder that may originate from improper 
dispersion in addition to low binder viscosity, low particle surface area and high difference 
between the densities of the two phases [72]. Further increasing the pressure either thickens 
the mat layer or discharges it (Figure 1c) depending on the propensity of the system to wall-
slip [73–76]. The viscoplasticity of complex fluids, including gels and concentrated suspen-
sions and cements is always accompanied by slip at the wall [77–81]. The wall-slip behavior 
of concentrated suspensions always occurs on the basis of the apparent slip behavior which is 
generated by the formation of a slip layer consisting of pure binder (which is typically 1/16th 
to 1/8th of particle diameter) [82–84]: Understanding the conditions necessary for the devel-
opment of a contiguous slip layer at the wall is the key to prevent mat layer formation and 
the resulting flow instabilities including filter-pressing and clogging [85]. The development 
of the apparent slip layer as well as the shear viscosity of the suspension as a function of time 
is affected by the role that entrained air plays. Wall-slip and shear viscosity of the suspension 
are both intimately linked to the amount of air that is entrained during mixing and processing 
[86–90]. Another important factor which affects the flow and deformation behavior of concen-
trated suspensions is linked directly to the efficacy of the distributive and dispersive mixing 
of the ingredients of the formulation and the possible shear-induced migration of particles 
during flow [91–95].
The solid mat layer in a cement is thickened as filtration progresses, setting continues, the liq-
uid content decreases or the solid packing increases, as a result of which the pressure required 
Figure 1. Stable flow (a), destabilized flow due to mat formation (b), stabilized flow due to mat formation (c) in capillary 
and the associated variation in the pressure drop (adapted with permission from Kalyon and Aktas et al. [72]).
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to induce both liquid flow and mat discharge increases. This self-feeding loop gradually trans-
forms the suspension to a packed bed at an increasing rate as evidenced by the exponential 
nature of the pressure vs. time curves of unstably flowing suspensions. Empirical attempts to 
tackle the filter-pressing issue shows that the injectability of CPCs is generally improved by 
decreasing the P/L ratio, the use of finer, round particles, the addition of electrically stabilizing 
groups, and the addition of viscous polymer solutions [96–101]. In addition to a large num-
ber of parameters relating to CPC composition, the injectability of a setting cement depends 
strongly on the post-mixing time interval relative to the cement setting time. In this regard, 
premixed CPCs that do not harden until being placed into the defect constitutes an advantage 
in that the viscoelastic properties are independent of time prior to injection [102].
3.4. Bioresorbability
Calcium phosphate cements are able to provide short-term biologically desirable properties 
and then be replaced by a new bone. In order to achieve optimum clinical results, an appro-
priate CPC resorption rate is an important parameter that may vary with the intended clinical 
applications. For critical applications close to vital organs like cranioplasty, rapid implant 
resorption and replacement by bone may not be an as important factor as implant stability 
and integrity, and even may not be desirable due to the sensitivity of the brain to local ionic 
concentration gradients. For other applications, such as periodontal bone defect repairs or 
sinus lift, the ability of the implant cement to be replaced quickly by bone is highly desir-
able. Studies on the in vivo evaluation of macroporous calcium phosphate cements revealed a 
higher bioresorption rate due to both a higher contact with body fluids and enhanced cellular 
activity due to particle degradation. When the bioresorbability of dense and macroporous 
α-tricalcium phosphate cement were compared, it was seen that pores formed by albumin 
foaming promoted bone ingrowth and replacement [103]. Introduction of macroporosity to 
the CPC causes a trade-off between strength and bioresorbability which should be compen-
sated by some means of strength reinforcement such as incorporation of polymeric fibers.
The overall bioresorption behavior of calcium phosphate cement is a combination of a solu-
tion-mediated passive resorption process and a cell-mediated active resorption process. The 
resorption properties of bioceramics are generally believed to relate to the solubility of their 
constitutive phases. The much higher (3 orders of magnitude) solubility of brushite compared 
to hydroxyapatite translates as the much quicker resorption of brushite cements. An impor-
tant in vivo characteristic of HA-forming CPC is that it does not dissolve spontaneously in a 
normal physiological fluid environment, yet is resorbable under cell-mediated acidic condi-
tions. Although brushite is soluble in normal physiological fluids, studies have shown that 
resorption of brushite CPC was also essentially cell-mediated [3]. Phase changes often occur 
in brushite cements in vivo by a dissolution-reprecipitation reaction, which results in stable 
phases with lower solubility, thus slowing down degradation and hence bone regeneration 
kinetics. The kinetics of passive resorption depends on porosity of the samples, ionic substitu-
tions, Ca:P ratio, crystallinity and pH of the cement-tissue interface. The active resorption is 
due to cellular activity; however, it is also related to the passive one. Serum pH near macro-
phages and osteoclasts can drop to 5 by the excretion of lactic acid, whereas near osteoblasts 
pH can become as high as 8.5 by the excretion of ammonia [12]. The micropores in hard-
ened cements do not allow fast bone ingrowth and they are not interconnected unless special 
Cement Based Materials200
efforts have been performed. Due to these reasons osteoclastic cells are able to degrade the 
hardened cements layer-by-layer only, starting at the bone cement interface. This is the main 
drawback of the classical cement formulations without controlled macroporous architecture. 
Bone substitution rate also depends on the anatomic site, age, sex, and general metabolic 
health of the recipient. Considering these factors, it may take 3–36 months for the cement to 
be completely resorbed and replaced by bone [26]. A linear degradation rate of 0.25 mm/week 
has been reported in literature [104].
Various ions of zinc, magnesium, fluoride and pyrophosphate have been observed to 
inhibit β-TCP and HA dissolution [105–107]. HA dissolution is also inhibited by the pres-
ence of compounds such as bisphosphonates, polyphosphates or pyrophosphoric acid [108]. 
Bisphosphonates which are metabolically stable analogs of pyrophosphate, bind strongly 
to hydroxyapatite crystals and suppress osteoclast-mediated bone resorption and crystal 
growth. The oxygen atom that binds the two phosphate groups of pyrophosphate (P▬O▬P) 
is substituted by a carbon atom (P▬C▬P) in bisphosphonates. Bisphosphonates are charac-
terized by the two covalently bonded sidechains attached to the central carbon atom, termed 
R1 and R2. Binding to bone is enhanced when R1 is a hydroxyl group, whereas the R2 side 
group has some effect on binding but predominantly determines the antiresorptive potency 
of the bisphosphonates. Bisphosphonates with an R2 side chain containing a basic primary 
nitrogen atom in an alkyl chain like pamidronate and alendronate are more potent antire-
sorptive agents than either etidronate or clodronate, whereas compounds with more highly 
substituted nitrogen moieties in R2 such as ibandronate can display further increases in anti-
resorptive potency [109].
Resorption of calcium phosphate cements is not desired at the onset of hardening in vivo 
due to washout of loose calcium phosphate particles by the surrounding body fluid before 
maintaining mechanical rigidity. The implant should be placed into the wound site between 
the initial and final setting times therefore washout constitutes a problem for the cement for-
mulations with long setting time. Besides improving the setting times, it is possible to have a 
coherent cement prior to implantation that sets in contact with body fluids. These are called 
premixed cements and are essentially pastes formed by calcium phosphate particles mixed 
with non-aqueous but water-miscible liquids like glycerol [100]. Also several studies show 
that incorporation of a gelling agent such as hydroxypropyl methylcellulose, carboxymethyl 
cellulose, alginate, chitosan, into CPC provides good washout resistance [110, 111]. However, 
generally premixed CPC have lower mechanical properties probably related to the volume 
initially taken up by the non-aqueous liquid [3].
4. Thermochemistry and setting kinetics
Dissolution of the initial calcium phosphates and mass transport are the primary functions 
of the aqueous CPC setting solution, in which the dissolved reactants form a supersaturated 
microenvironment with regard to precipitation of the final product. The relative stability and 
solubility of various calcium phosphates is the major driving force for the setting reactions 
that occur in various cement formulations. Mixing of calcium phosphate precursors with 
aqueous setting solution induces various chemical transformations, where crystals of the initial 
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calcium phosphates dissolve and precipitate into crystals of HA or brushite. When powders 
of calcium oxides are mixed with an acid-phosphate solution, they dissolve at various rates in 
the solvent and release calcium cations in the solution. These cations react with the phosphate 
anions at various rates within the solvent and form a precipitate of salt molecules. Thus, CPC 
setting is a result of the following three steps [112]:
I. The acid phosphates dissolve in water, release phosphate anions, and form an acid-phos-
phate solution of low pH.
II. The calcium oxides dissolve gradually in the low pH solution and release Ca2+ cations.
III. The phosphate anions react with the newly released cations and form a coordinated net-
work and consolidate into a CPC
The conditions to form a CPC are governed by the rate of reactions that control each of these 
three steps. The growth kinetics is mainly controlled by phosphate incorporation step, and 
additives interfering with this step regulate precipitation and crystal growth. Adsorbed atoms 
from the solution have to be removed during crystal growth to accommodate the competing 
HPO
2
4− ion; hence, dehydration or impurity de-adsorption is an important part of the activa-
tion barrier for growth and dissolution [113]. Since acid-phosphate reactants such as DCP, 
monocalcium phosphate monohydrate (MCPM), or orthophosphoric acid (PA) are generally 
soluble, their dissolutions rates are comparatively high, hence uncontrollable. The phosphate 
reaction between dissolved cations and anions described in step III is also inherently fast and 
may be kinetically constrained to the formation of intermediate precursor phases according to 
the Ostwald’s rule of stages. Thus, the only reaction that can be controlled is the dissolution of 
calcium oxides given in step II. Particle size [114, 115], crystallinity [116], powder/liquid ratio 
[117], precursor chemistry [105], Ca:P ratio [118], temperature [44], surface charge [69], liquid 
pH [119], ionic strength [34], and concentration of stabilizing, setting promoting or retarding 
chemicals [120–122] may significantly affect the rate of dissolution and the consequent setting 
time of CPC. α-TCP is a calcium oxide that dissolves fast and also reacts fast. On the other 
hand β-TCP dissolution rate is too low in neutral water, so that it remains mostly unreacted in 
a solution with a slightly acidic phosphate source. For this reason appropriate calcium oxides, 
based on their solubility, should be selected in combination with suitable acid-phosphate 
counterparts to synthesize CPCs [123].
Relative stability of different calcium phosphate salts in equilibrium with their saturated solu-
tion for different pH values can be understood from Figure 2 showing the solubility isotherms 








O at 25°C according to the solubility constants given 
in literature [124]. These isotherms have a negative slope in the neutral and acid regions of the 
solubility diagrams which point to the fact that calcium phosphates become more soluble as 
the pH decreases. The gradient of the slopes indicates the solubility increase of the salt as the 
pH decreases. Therefore the isotherm slope is considered as a measure of the salt basicity and 
DCPD and DCP are acid salts in comparison to OCP, α-TCP, β-TCP, HA and TTCP because 
they have lower negative slopes [125]. The isotherms show that the amount dissolved at equi-
librium depends on the pH of the solution and the thermodynamic solubility product of the 
compound which is a function of both crystal and solution chemistry and physical properties.
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Accordingly, HA is the least soluble salt down to a pH of 4.2; for pH values lower than this, 
DCP is the least soluble salt. Also, it can be observed for pH values lower than 8.5 that the 
most soluble salt is TTCP; and for pH values higher than 8.5 that the most soluble salt is 
DCPD. TTCP and DCP were used as the precursors in the first apatite CPC not fully coinci-
dentally because these are the most soluble salts and thus would provide the greatest driv-
ing force for the HA-forming reaction. Since at a pH above 4.2, all other calcium phosphate 
compounds are more soluble than HA, they can be used as precursors for apatite cements. 
Although several calcium phosphate phases, such as OCP and whitlockite (not shown in fig-
ure), are more soluble than HA under neutral pH conditions, they have been found as the 
major phase in the cement products [126, 127]. This is because these metastable phases precip-
itate in preference to HA according to the Ostwald’s rule of stages [128], and finally convert 
to HA. Homogeneous formation of HA at low concentrations is almost never observed due to 
the activation energy barrier for nucleation that should be overcome with high supersatura-
tion. At the onset of precipitation, initial supersaturation is the thermodynamic driving force. 
It is demonstrated by Song et al. for a batch system that after the fast precipitation in the early 
stage, the following precipitation becomes very slow due to the decrease of supersaturation 
of the solution with the depletion of calcium and phosphate ions [129]. The fast precipitation 
cannot continue because there is no supply of extra calcium and phosphate ions. However 
at a semi-batch system such as that of a CPC, where time dependent dissolution of precur-
sor calcium phosphates supplies ions for supersaturation, the fast precipitation can be kept 
provided that suitable pH value and concentrations of calcium and phosphate are present.
Figure 2. Calcium ion concentration of various calcium phosphate compounds as functions of solution pH.
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Although the likelihood of precipitation of a particular calcium phosphate phase is ultimately 
determined by the thermodynamic driving force of formation, kinetic factors may be considerably 
more important in controlling the nature of the solids formed. Ostwald’s Rule of Stages postulated 
in 1897 states that the crystal phase that nucleates in a supersaturated solution is not the phase that 
is thermodynamically stable at that temperature and pressure but rather another metastable phase 
that is closest in free energy to the parent phase [130]. There are also examples of phase transfor-
mations where a metastable phase exists but does not form due to immediate transformation into 
another phase. It is possible to observe the metastable intermediate by slowing down the kinetics 
of the reaction. According to the Ostwald’s rule of stages, the nucleated phase is the phase that has 
the lowest free-energy barrier of formation of a critical radius  R 
c
 (having the lowest critical radius), 
rather than the phase that is thermodynamically stable (having the highest supersaturation). In 
classical nucleation theory [131], the free energy of formation  ∆ G , and the activation energy for 
nucleation  ∆  G ∗ are related to the surface energy  γ , density  ρ , and the difference between the chemi-
cal potentials of the products and the reactants  ∆ μ which is basically a function of the supersatura-
tion  S with respect to the precipitating phase, which is the driving force for nucleation:
  ∆ G = 4π  R 2  γ +  4 __
3
 π  R 3  ρ ∆ μ  (4)
  R 
c
  =  − 2γ ____ ρ ∆ μ (5)
where
  ∆ μ = − kTlnS (6)
and
  S =  Ionic activity product  ________________________
Solubility product  ( K sp ) 
 (7)
The ionic activity product of a calcium phosphate phase is the product of the concentration of 
the constituent ions and their activity coefficients. The activity coefficients are also complex 
functions of the interactions between ions in the solution as expressed by the Pitzer’s thermo-
dynamical model for electrolytes [132], hence ionic strength. Brown and Chow have shown 
that the thermodynamic solubility product depends on the purity of the calcium phosphate, 
which in turn, depends on the method of preparation [133]. Substitute ions like fluoride, car-
bonate and magnesium influence the structure of the calcium phosphates and therefore have 
specific effects on their solubilities [134].
Generally two types of CPC setting reactions are observed, the most common one is the setting 
reaction that occurs according to an acid-base reaction, i.e., a relatively acidic calcium phos-
phate phase reacts with a relatively basic one to produce a more or less neutral calcium phos-
phate salt [135]. Typical examples are the cement of Brown and Chow, where TTCP (basic) 
reacts with DCP (slightly acidic) to form PHA (slightly basic), the cement of Lemaitre where 
β-TCP, (slightly basic) reacts with MCPM (acidic) to form DCPD (neutral), and a variation of 
Lemaitre’s formulation where MCPM is substituted by PA while β-TCP is replaced by CDHA 
according to the reactions:
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  Ca 
4
   ( PO 4 ) 2  O +  CaHPO 4  →  Ca 5   ( PO 4 ) 3  OH (8)
  β −  Ca 
3
   ( PO 4 ) 2 + Ca  ( H 2   PO 4 ) 2  . H 2  O +  7H 2  O → 4  CaHPO 4  . 2H 2  O (9)
  Ca 
9
 ( HPO 4 )   ( PO 4 ) 5  OH +  3H 3   PO 4 + 17  H 2  O → 9  CaHPO 4  . 2H 2  O (10)
The TTCP + DCPD and TTCP + DCP combinations have been the most studied [136]. They 
offer hardening at a suitable time at body or room temperature within a neutral pH range. 
From a theoretical standpoint, any calcium phosphate that is more acidic than HA can react 
directly with TTCP to form PHA or CDHA according to the following reactions:
  7  Ca 
4
   ( PO 4 ) 2  O + 2 Ca  ( H 2   PO 4 ) 2  . H 2  O → 6  Ca 5   ( PO 4 ) 3  OH + 3  H 2  O (11)
  2  Ca 
4
   ( PO 4 ) 2  O + Ca  ( H 2   PO 4 ) 2  . H 2  O →  Ca 9 ( HPO 4 )   ( PO 4 ) 5  OH + 2  H 2  O (12)
  Ca 
4
   ( PO 4 ) 2  O +  CaHPO 4  . 2H 2  O →  Ca 5   ( PO 4 ) 3  OH + 2  H 2  O (13)
  3  Ca 
4
   ( PO 4 ) 2  O + 6  CaHPO 4  . 2H 2  O → 2  Ca 9 ( HPO 4 )   ( PO 4 ) 5  OH + 13  H 2  O (14)
  Ca 
4
   ( PO 4 ) 2  O +  CaHPO 4  →  Ca 5   ( PO 4 ) 3  OH (15)
  3  Ca 
4
   ( PO 4 ) 2  O + 6  CaHPO 4  → 2  Ca 9 ( HPO 4 )   ( PO 4 ) 5  OH +  H 2  O (16)
  3  Ca 
4
   ( PO 4 ) 2  O +  Ca 8   H 2   ( PO 4 ) 6  . 5H 2  O → 4  Ca 5   ( PO 4 ) 3  OH + 4  H 2  O (17)
  3  Ca 
4
   ( PO 4 ) 2  O + 3  Ca 8   H 2   ( PO 4 ) 6  . 5H 2  O → 4  Ca 9 ( HPO 4 )   ( PO 4 ) 5  OH + 14  H 2  O (18)
  Ca 
4
   ( PO 4 ) 2  O + 2  Ca 3   ( PO 4 ) 2 +  H 2  O →  2Ca 5   ( PO 4 ) 3  OH (19)
It is also possible to form HA from acid-base mixtures of calcium phosphates with a Ca/P 
lower than that of HA when an additional source of calcium ions instead of TTCP is pres-




. [137, 138] Takagi et al. were the first to propose a calcium 
phosphate cement formulation without TTCP. Different combinations of DCP and DCPD, 
α-TCP, amorphous calcium phosphate (ACP), calcium hydroxide and calcium carbonate 
have been prepared to obtain improvements in the setting time to as low as 5 minutes and 
tensile strengths as high as 7.5 MPa [139].
All brushite CPCs are obtained by an acid–base reaction. Because DCPD and DCP are the 
least soluble calcium phosphates under acidic pH (<4.2), they are the products formed by 
acidic CPC formulations. All other calcium phosphate phases being more soluble under these 
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pH conditions, can be used as precursors for the DCPD- or DCP-forming cements. Although 
DCP is the more stable of the two phases, it is kinetically constrained to have a higher nucle-
ation activation energy and can only form under certain conditions as explained earlier. After 
setting, the pH of the cement paste slowly changes towards the equilibrium pH [140]. Up to 





and TTCP + MCPM + CaO [51, 99, 141].
The second type of setting reaction is defined as hydrolysis of a metastable calcium phosphate 
when the reactant and the product have the same Ca/P molar ratio. Typical examples are 
ACP, α-TCP, and TTCP which form CDHA upon contact with an aqueous solution:
  Ca 
x
   H 
y
   ( PO 4 ) z  . nH 2  O +  H 2  O →  Ca 10−x   ( HPO 4 ) x   ( PO 4 ) 6−x   (OH) 2−x +  nH 2  O (20)
  3 α −  Ca 
3
   ( PO 4 ) 2 +  H 2  O →  Ca 9 ( HPO 4 )   ( PO 4 ) 5  OH (21)
  3  Ca 
4
   ( PO 4 ) 2  O + 3  H 2  O →  Ca 9 ( HPO 4 )   ( PO 4 ) 5  OH + 3Ca  (OH) 2 (22)
Chemical composition of calcium phosphate cements may include all ionic compounds of 
naturally occurring minerals in human body. The list of possible additives includes the follow-















−, Cl−, F−, SiO
4
4−. Therefore, mixed-type cements consisting of calcium phos-
phates and other calcium salts like gypsum, calcium sulfate hemihydrate, calcium pyrophos-
phate, calcium polyphosphates, calcium carbonate, calcium oxide, calcium hydroxide, calcium 
aluminate, calcium silicate, strontium phosphate, as well as cements made of ion substituted 










Ca6(PO4)5, magnesium-substituted calcium deficient hydroxyapatite (CDHA), strontium-substituted CDHA are possible [142].
CO
3
2− ions have the most significant effect on CPC microstructure such that incorporation 
of carbonate in the apatite cement causes a decrease in the precipitated crystallite size and 
reduces the setting rate as well as the attained compressive strength. According to the study 
by Khairoun et al. CaCO
3
 addition extended the initial setting times but significantly short-
ened the final setting times of single component HA cement. Furthermore its accelerating 
effect was more pronounced at higher concentrations [137]. Morphological studies reveal 
that the size and shape of the crystallites change from long needles to smaller rods to tiny 
spheroids [18, 102]. Carbonate ions can incorporate into apatite and substitute for PO
4
3− or 
OH− in the apatite crystal structure and subsequently change its properties. It is reported that 
the supersaturation required for precipitation of slightly carbonated apatite was higher than 
that of apatite in simulated body fluid [143]. Carbonate ions disturb the crystallization of the 
growing apatite crystallites to such an extent that, depending upon the amount of carbonate 
added, the material may give an amorphous X-ray diffraction pattern. A submicron structure 
of interconnected microcrystals are responsible for the improved final mechanical proper-
ties of the cement formulation with addition of calcium carbonate. Moreover, carbonate ions 
cause the bonding in the apatite to become weaker and more isotropic, which results in the 
small spheroidal crystals and in faster dissolution rates [42].
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Similarly, many carboxyl group containing acids and salts have significant effect on hydroxy-
apatite microstructure and in general setting kinetics of calcium phosphate cements. A num-
ber of α-hydroxylated carboxylic acids and salts readily form calcium complexes as well as 
relatively insoluble and often amorphous Ca-carboxylate compounds [56]. These include 
glycolic, citric, tartaric, malonic, malic, succinic, lactic and maleic acids. Upon application of 
precompaction, compressive strength of TTCP-DCP cement increased fourfold to 184 MPa 
with sodium citrate concentration up to 500 mM compared to plain water and citric acid 
cement liquid [144]. Sodium citrate addition changed the surface zeta potentials of TTCP 
and DCP to −50.6 and −50.1 mV with 50 mM sodium citrate from −15.0 and −18.4 mV with 
water.
5. Phase evolution during setting
The powder of the original calcium phosphate cement formulation proposed by Brown and 
Chow consists of an equimolar mixture of TTCP and DCP. The setting reaction of calcium 
phosphate cements starts with ordered dissolution of the salts in the aqueous system. This 
supplies Ca2+ and PO
4
3− ions, which precipitate in the form of HA. Epitaxial enlargement of 
petal or needle-like crystals after initial setting is responsible for the adherence and inter-
locking of the crystalline grains, which result in hardening [26]. Detailed investigations 
of the setting of various CPC formulation using various molar ratios, particle sizes, P/L 
ratios reveal that the reaction proceeds by complete dissolution of the acidic phases DCP 
or MCPM and partial dissolution of the basic TTCP or β-TCP particles. The specific surface 
area and the resulting solubility of the basic phase has a much greater effect on the setting 
rate as increasing its specific surface area leads to an increase in pH, and results in a sharp 
rise in the solubility of the acidic particles and the supersaturation of HA in the solution 
[40]. For apatite cement setting is controlled by the dissolution of reactant particles in the 
first 4-h period, and since the rate of dissolution is proportional to the surface area of the 
particles which is basically constant in CPC specimens in the earlier stage, the precipita-
tion rate of HA is linear with time. HA forms among the reactant particles which enhances 
the joint of solids, or around the particles which reduces the distance between grains [42]. 
Setting is controlled by diffusion through the HA layer at later stages. At 24 hours, the crys-
tals are completely formed, being highly compacted in some areas of high density and well 
separated in areas with more porosity. Precipitated HA either in stoichiometric or calcium 
deficient form, nucleate and grow on TTCP particles, thereby reducing their dissolution rate 
at the final stages [145]. When such a shell is formed around the reactants, the rate of HA 
formation is controlled by the transport of water and ions through the shell and decrease 
with an increase of its thickness. Since the densities of DCP and HA are different, the hydra-
tion of the residual DCP engulfed by the shell to HA leads to volume expansion and internal 
stress which is harmful to the compressive strength.
Liu et al. describes the thermodynamics of apatite cement setting clearly [118]. Calcium phos-
phate cement setting reactions are generally exothermic reactions consisting of several steps. 
In the short initiating period, water is absorbed and wets the surface of the grains upon mixing 
calcium phosphate powder with water. This is a physical exothermic process. In the inducing 
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period or latency, the particle dissolution which is also exothermic contributes to a rise in con-
centration of the calcium and phosphate ions in the solution. With the different dissolution 
rates of the basic and acidic precursors and the latter being faster, initially acidic pH translates 
toward the neutral or basic region until the solution is supersaturated, and then DCPD or HA 
crystallizes from the solution. The accelerating period is a fast, reaction controlled region. In 
the decelerating period, setting reaction decreases and the reaction process converts from 
surface reaction-controlled to diffusion-controlled after the setting product grows around the 
particle surface of the raw materials. Finally, the precipitate product layer may be destroyed 
by osmotic pressure and crystallization interior stress, which may lead to the increase of the 
reaction rate and another slight exothermic peak.
The phase evolution of brushite forming β-TCP—MCPM system has been monitored by 
various techniques including FTIR spectroscopy [146], DS calorimetry [117], pH-stat base 
titration [33, 34] and small amplitude oscillatory rheometry [44]. The observations con-
firm the above-mentioned general thermodynamic changes in the state of the CPC. Upon 









− is expected to 
dissociate into H+ and HPO
4
2− ions due to its relative stability among phosphoric acid spe-
cies in water at room temperature [83]. β-TCP dissolves simultaneously to release 3Ca2+ 
and 2PO
4




O provided that stoichiometric H+ ions are 
removed from the solution to first form HPO
4
2−groups, resulting in an initial rise in solu-
tion pH that is an indication of supersaturation build-up. At this stage cement injectability 
is maximum. Subsequent to this period, the injectability of CPC gradually diminishes as 
crystal domains start to expand and intergrow with increasing β-TCP dissolution. Built-up 
supersaturation can quickly relax by crystal growth in the presence of brushite seeds. 
As crystals intergrow into small domains, cements gain dough consistency and elastic-
ity develops as seen in Figure 3. With increasing intergrowth of the crystalline phase the 
suspension becomes thicker, i.e., more viscous and more elastic as defined by the increases 
of the storage modulus, G′ and the magnitude of complex viscosity, η* occurring between 
the dough time and the initial setting time. CPC is workable by hand prior to the dough 
time as it lacks stiffness and rigidity. Subsequent precipitation and β-TCP dissolution act 
to balance the supersaturation and pH until the rate of one weakens relative to the other 
[147]. This interplay between dissolution and precipitation continues indefinitely until the 
consumption of precursors.
After the working period a particle to particle network develops and the injectability of the 
doughy cement suspension becomes modestly more difficult as the initial setting time is 
approached [148]. Bone cements with various solid contents have been reported to be inject-
able well beyond their dough time [67] which is most likely due to the active wall-slip mecha-
nism that enables stable flow of doughy pastes. Cement suspension can be shaped by hand 
at this working period when it has a dough consistency and does not stick to surgical gloves. 
At the initial setting time a solid network structure or gelling starts to develop in cement 
microstructure when elasticity and viscosity starts to overshoot asymptotically. The visco-
elastic properties change abruptly during this setting period with a sudden transition from 
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viscous to elastic flow behavior and elasticity increases at a decreasing rate as a function of the 
dissolution rate which depends on the β-TCP and water content. Flow instabilities naturally 
build pressure drop up constantly beyond that point as a result of which injection becomes 
impractical.
A recent development on improvement of injectability or extrudability of calcium phosphate 
cements was introduced by our research group so that the inherent injectability problem can 
be solved by conditioning the cement prior to injection by preshearing. [44]. Our observation 
that application of oscillatory and steady shear strains i.e. preshearing alters both the setting 
kinetics and the microstructure, enables tailoring of the cement viscosity and the injection, 
working and setting periods. The rheology of fast-setting brushite cement was also charac-
terized (Figure 3) including the linear viscoelastic strain limit which was characterized for 
inorganic cements as a function of setting time for the first time. A preshearing apparatus 
akin to a syringe with the capability to not only pressurize but also mix, preshear and dis-
pense cements in situ is designed to facilitate their effective handling and injection. This novel 
mechanical modification technique is applicable to most inorganic cements and opens an 
avenue for further research on modification of cement properties, especially rheology with-
out resorting to chemical additives that may compromise the bioactivity and other favorable 
properties. The beneficial effects of preshearing on workability and extrudability of inorganic 
cements promise exciting new applications for them such as direct 3D printing of micro- and 
macroporous scaffolds for bone regeneration.
Figure 3. Schematics of calcium phosphate cement setting as represented by the dynamic rheological properties (Şahin 
and Kalyon [44]).
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